• Strategic deal will extend Think’s clinical electronic data capture footprint 
  • SaaS acquisition to be accretive and expected to expand Think’s software reach

TORONTO, ON, November 4, 2021 – Think Research Corporation (TSXV: THNK) (“Think” or the “Company“), a company focused on transforming healthcare through digital health software solutions, is pleased to announce today it has acquired the assets of Pharmapod Limited (“Pharmapod”) through a receivership process in Ireland (the “Transaction”) pursuant to the terms of a business purchase agreement dated November 4, 2021 (the “Business Purchase Agreement”), between Think, Pharmapod, a receiver appointed in respect of Pharmapod, and Think’s wholly-owned subsidiary, Think Research (EU) Corporation Limited (“Think Research EU”). Pharmapod operates a software as a service (“SaaS”) electronic data capture solution that reports medication errors to improve patient safety and simplify pharmacy reporting. 

Through the Transaction, Think will be uniquely positioned to service pharmacies, hospitals and long-term care facilities around the world by building upon the current reach of Think’s electronic data capture solutions and client base. Pharmapod services more than 9,000 pharmacies throughout Canada, the United Kingdom, Ireland and Australia, including over 7,400 pharmacies in Canada, representing 65% of all Canadian retail pharmacies. Pharmapod also services a certified US retail online pharmacy, with fulfillment locations throughout the continental United States.  

Visit the Think Research website to read the full press release

Recent Posts

Further Education

Learning and Development

The Rising Prevalence of Skin Cancer in Canada

Posted 26 May 22

Further Education

Learning and Development

Digital Healthcare 101: What is Digital Medicine?

Posted 10 May 22

Further Education

New Chapter in Digital Health: e-Prescribing

Posted 17 Mar 22